Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

The global Intravenous (IV) Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.

In terms of product, Crystalloids is the largest segment, with a share over 76%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Solution.

Report Scope

The Intravenous (IV) Solution market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous (IV) Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intravenous (IV) Solution manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Intravenous (IV) Solution Market Report

Report Metric	Details
Report Name	Intravenous (IV) Solution Market
Segment by Type	Total Parenteral Solution Peripheral Parenteral Solution
Segment by Application	Hospitals & Clinics Ambulatory Homecare
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	ICU Medical, B. Braun Melsungen, Fresenius Kabi, Baxter, Amanta Healthcare, Terumo Medical, Grifols
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous (IV) Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous (IV) Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

What is the market share of major companies in Intravenous (IV) Solution Market?

Ans: Global top three manufacturers hold a share over 35%.

Who are the main players in the Intravenous (IV) Solution Market report?

Ans: The main players in the Intravenous (IV) Solution Market are ICU Medical, B. Braun Melsungen, Fresenius Kabi, Baxter, Amanta Healthcare, Terumo Medical, Grifols

What are the Application segmentation covered in the Intravenous (IV) Solution Market report?

Ans: The Applications covered in the Intravenous (IV) Solution Market report are Hospitals & Clinics, Ambulatory, Homecare

What are the Type segmentation covered in the Intravenous (IV) Solution Market report?

Ans: The Types covered in the Intravenous (IV) Solution Market report are Total Parenteral Solution, Peripheral Parenteral Solution

1 Intravenous (IV) Solution Market Overview

1.1 Product Overview and Scope of Intravenous (IV) Solution

1.2 Intravenous (IV) Solution Segment by Type

1.2.1 Global Intravenous (IV) Solution Market Value Comparison by Type (2024-2030)

1.2.2 Total Parenteral Solution

1.2.3 Peripheral Parenteral Solution

1.3 Intravenous (IV) Solution Segment by Application

1.3.1 Global Intravenous (IV) Solution Market Value by Application: (2024-2030)

1.3.2 Hospitals & Clinics

1.3.3 Ambulatory

1.3.4 Homecare

1.4 Global Intravenous (IV) Solution Market Size Estimates and Forecasts

1.4.1 Global Intravenous (IV) Solution Revenue 2019-2030

1.4.2 Global Intravenous (IV) Solution Sales 2019-2030

1.4.3 Global Intravenous (IV) Solution Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Intravenous (IV) Solution Market Competition by Manufacturers

2.1 Global Intravenous (IV) Solution Sales Market Share by Manufacturers (2019-2024)

2.2 Global Intravenous (IV) Solution Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Intravenous (IV) Solution Average Price by Manufacturers (2019-2024)

2.4 Global Intravenous (IV) Solution Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Intravenous (IV) Solution, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Intravenous (IV) Solution, Product Type & Application

2.7 Intravenous (IV) Solution Market Competitive Situation and Trends

2.7.1 Intravenous (IV) Solution Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Intravenous (IV) Solution Players Market Share by Revenue

2.7.3 Global Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Intravenous (IV) Solution Retrospective Market Scenario by Region

3.1 Global Intravenous (IV) Solution Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Intravenous (IV) Solution Global Intravenous (IV) Solution Sales by Region: 2019-2030

3.2.1 Global Intravenous (IV) Solution Sales by Region: 2019-2024

3.2.2 Global Intravenous (IV) Solution Sales by Region: 2025-2030

3.3 Global Intravenous (IV) Solution Global Intravenous (IV) Solution Revenue by Region: 2019-2030

3.3.1 Global Intravenous (IV) Solution Revenue by Region: 2019-2024

3.3.2 Global Intravenous (IV) Solution Revenue by Region: 2025-2030

3.4 North America Intravenous (IV) Solution Market Facts & Figures by Country

3.4.1 North America Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Intravenous (IV) Solution Sales by Country (2019-2030)

3.4.3 North America Intravenous (IV) Solution Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Intravenous (IV) Solution Market Facts & Figures by Country

3.5.1 Europe Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Intravenous (IV) Solution Sales by Country (2019-2030)

3.5.3 Europe Intravenous (IV) Solution Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Intravenous (IV) Solution Market Facts & Figures by Country

3.6.1 Asia Pacific Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Intravenous (IV) Solution Sales by Country (2019-2030)

3.6.3 Asia Pacific Intravenous (IV) Solution Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Intravenous (IV) Solution Market Facts & Figures by Country

3.7.1 Latin America Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Intravenous (IV) Solution Sales by Country (2019-2030)

3.7.3 Latin America Intravenous (IV) Solution Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Intravenous (IV) Solution Market Facts & Figures by Country

3.8.1 Middle East and Africa Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Intravenous (IV) Solution Sales by Country (2019-2030)

3.8.3 Middle East and Africa Intravenous (IV) Solution Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Intravenous (IV) Solution Sales by Type (2019-2030)

4.1.1 Global Intravenous (IV) Solution Sales by Type (2019-2024)

4.1.2 Global Intravenous (IV) Solution Sales by Type (2025-2030)

4.1.3 Global Intravenous (IV) Solution Sales Market Share by Type (2019-2030)

4.2 Global Intravenous (IV) Solution Revenue by Type (2019-2030)

4.2.1 Global Intravenous (IV) Solution Revenue by Type (2019-2024)

4.2.2 Global Intravenous (IV) Solution Revenue by Type (2025-2030)

4.2.3 Global Intravenous (IV) Solution Revenue Market Share by Type (2019-2030)

4.3 Global Intravenous (IV) Solution Price by Type (2019-2030)

5 Segment by Application

5.1 Global Intravenous (IV) Solution Sales by Application (2019-2030)

5.1.1 Global Intravenous (IV) Solution Sales by Application (2019-2024)

5.1.2 Global Intravenous (IV) Solution Sales by Application (2025-2030)

5.1.3 Global Intravenous (IV) Solution Sales Market Share by Application (2019-2030)

5.2 Global Intravenous (IV) Solution Revenue by Application (2019-2030)

5.2.1 Global Intravenous (IV) Solution Revenue by Application (2019-2024)

5.2.2 Global Intravenous (IV) Solution Revenue by Application (2025-2030)

5.2.3 Global Intravenous (IV) Solution Revenue Market Share by Application (2019-2030)

5.3 Global Intravenous (IV) Solution Price by Application (2019-2030)

6 Key Companies Profiled

6.1 ICU Medical

6.1.1 ICU Medical Corporation Information

6.1.2 ICU Medical Description and Business Overview

6.1.3 ICU Medical Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)

6.1.4 ICU Medical Intravenous (IV) Solution Product Portfolio

6.1.5 ICU Medical Recent Developments/Updates

6.2 B. Braun Melsungen

6.2.1 B. Braun Melsungen Corporation Information

6.2.2 B. Braun Melsungen Description and Business Overview

6.2.3 B. Braun Melsungen Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)

6.2.4 B. Braun Melsungen Intravenous (IV) Solution Product Portfolio

6.2.5 B. Braun Melsungen Recent Developments/Updates

6.3 Fresenius Kabi

6.3.1 Fresenius Kabi Corporation Information

6.3.2 Fresenius Kabi Description and Business Overview

6.3.3 Fresenius Kabi Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Fresenius Kabi Intravenous (IV) Solution Product Portfolio

6.3.5 Fresenius Kabi Recent Developments/Updates

6.4 Baxter

6.4.1 Baxter Corporation Information

6.4.2 Baxter Description and Business Overview

6.4.3 Baxter Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Baxter Intravenous (IV) Solution Product Portfolio

6.4.5 Baxter Recent Developments/Updates

6.5 Amanta Healthcare

6.5.1 Amanta Healthcare Corporation Information

6.5.2 Amanta Healthcare Description and Business Overview

6.5.3 Amanta Healthcare Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Amanta Healthcare Intravenous (IV) Solution Product Portfolio

6.5.5 Amanta Healthcare Recent Developments/Updates

6.6 Terumo Medical

6.6.1 Terumo Medical Corporation Information

6.6.2 Terumo Medical Description and Business Overview

6.6.3 Terumo Medical Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Terumo Medical Intravenous (IV) Solution Product Portfolio

6.6.5 Terumo Medical Recent Developments/Updates

6.7 Grifols

6.6.1 Grifols Corporation Information

6.6.2 Grifols Description and Business Overview

6.6.3 Grifols Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Grifols Intravenous (IV) Solution Product Portfolio

6.7.5 Grifols Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Intravenous (IV) Solution Industry Chain Analysis

7.2 Intravenous (IV) Solution Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Intravenous (IV) Solution Production Mode & Process

7.4 Intravenous (IV) Solution Sales and Marketing

7.4.1 Intravenous (IV) Solution Sales Channels

7.4.2 Intravenous (IV) Solution Distributors

7.5 Intravenous (IV) Solution Customers

8 Intravenous (IV) Solution Market Dynamics

8.1 Intravenous (IV) Solution Industry Trends

8.2 Intravenous (IV) Solution Market Drivers

8.3 Intravenous (IV) Solution Market Challenges

8.4 Intravenous (IV) Solution Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Intravenous (IV) Solution Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Intravenous (IV) Solution Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Intravenous (IV) Solution Market Competitive Situation by Manufacturers in 2023

Table 4. Global Intravenous (IV) Solution Sales (K MT) of Key Manufacturers (2019-2024)

Table 5. Global Intravenous (IV) Solution Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Intravenous (IV) Solution Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Intravenous (IV) Solution Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Intravenous (IV) Solution Average Price (USD/MT) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Intravenous (IV) Solution, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Intravenous (IV) Solution, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Intravenous (IV) Solution, Product Type & Application

Table 12. Global Key Manufacturers of Intravenous (IV) Solution, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Intravenous (IV) Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solution as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Intravenous (IV) Solution Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Intravenous (IV) Solution Sales by Region (2019-2024) & (K MT)

Table 18. Global Intravenous (IV) Solution Sales Market Share by Region (2019-2024)

Table 19. Global Intravenous (IV) Solution Sales by Region (2025-2030) & (K MT)

Table 20. Global Intravenous (IV) Solution Sales Market Share by Region (2025-2030)

Table 21. Global Intravenous (IV) Solution Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Intravenous (IV) Solution Revenue Market Share by Region (2019-2024)

Table 23. Global Intravenous (IV) Solution Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Intravenous (IV) Solution Revenue Market Share by Region (2025-2030)

Table 25. North America Intravenous (IV) Solution Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Intravenous (IV) Solution Sales by Country (2019-2024) & (K MT)

Table 27. North America Intravenous (IV) Solution Sales by Country (2025-2030) & (K MT)

Table 28. North America Intravenous (IV) Solution Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Intravenous (IV) Solution Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Intravenous (IV) Solution Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Intravenous (IV) Solution Sales by Country (2019-2024) & (K MT)

Table 32. Europe Intravenous (IV) Solution Sales by Country (2025-2030) & (K MT)

Table 33. Europe Intravenous (IV) Solution Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Intravenous (IV) Solution Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Intravenous (IV) Solution Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Intravenous (IV) Solution Sales by Region (2019-2024) & (K MT)

Table 37. Asia Pacific Intravenous (IV) Solution Sales by Region (2025-2030) & (K MT)

Table 38. Asia Pacific Intravenous (IV) Solution Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Intravenous (IV) Solution Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Intravenous (IV) Solution Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Intravenous (IV) Solution Sales by Country (2019-2024) & (K MT)

Table 42. Latin America Intravenous (IV) Solution Sales by Country (2025-2030) & (K MT)

Table 43. Latin America Intravenous (IV) Solution Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Intravenous (IV) Solution Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Intravenous (IV) Solution Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Intravenous (IV) Solution Sales by Country (2019-2024) & (K MT)

Table 47. Middle East & Africa Intravenous (IV) Solution Sales by Country (2025-2030) & (K MT)

Table 48. Middle East & Africa Intravenous (IV) Solution Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Intravenous (IV) Solution Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Intravenous (IV) Solution Sales (K MT) by Type (2019-2024)

Table 51. Global Intravenous (IV) Solution Sales (K MT) by Type (2025-2030)

Table 52. Global Intravenous (IV) Solution Sales Market Share by Type (2019-2024)

Table 53. Global Intravenous (IV) Solution Sales Market Share by Type (2025-2030)

Table 54. Global Intravenous (IV) Solution Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Intravenous (IV) Solution Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Intravenous (IV) Solution Revenue Market Share by Type (2019-2024)

Table 57. Global Intravenous (IV) Solution Revenue Market Share by Type (2025-2030)

Table 58. Global Intravenous (IV) Solution Price (USD/MT) by Type (2019-2024)

Table 59. Global Intravenous (IV) Solution Price (USD/MT) by Type (2025-2030)

Table 60. Global Intravenous (IV) Solution Sales (K MT) by Application (2019-2024)

Table 61. Global Intravenous (IV) Solution Sales (K MT) by Application (2025-2030)

Table 62. Global Intravenous (IV) Solution Sales Market Share by Application (2019-2024)

Table 63. Global Intravenous (IV) Solution Sales Market Share by Application (2025-2030)

Table 64. Global Intravenous (IV) Solution Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Intravenous (IV) Solution Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Intravenous (IV) Solution Revenue Market Share by Application (2019-2024)

Table 67. Global Intravenous (IV) Solution Revenue Market Share by Application (2025-2030)

Table 68. Global Intravenous (IV) Solution Price (USD/MT) by Application (2019-2024)

Table 69. Global Intravenous (IV) Solution Price (USD/MT) by Application (2025-2030)

Table 70. ICU Medical Corporation Information

Table 71. ICU Medical Description and Business Overview

Table 72. ICU Medical Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 73. ICU Medical Intravenous (IV) Solution Product

Table 74. ICU Medical Recent Developments/Updates

Table 75. B. Braun Melsungen Corporation Information

Table 76. B. Braun Melsungen Description and Business Overview

Table 77. B. Braun Melsungen Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 78. B. Braun Melsungen Intravenous (IV) Solution Product

Table 79. B. Braun Melsungen Recent Developments/Updates

Table 80. Fresenius Kabi Corporation Information

Table 81. Fresenius Kabi Description and Business Overview

Table 82. Fresenius Kabi Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 83. Fresenius Kabi Intravenous (IV) Solution Product

Table 84. Fresenius Kabi Recent Developments/Updates

Table 85. Baxter Corporation Information

Table 86. Baxter Description and Business Overview

Table 87. Baxter Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 88. Baxter Intravenous (IV) Solution Product

Table 89. Baxter Recent Developments/Updates

Table 90. Amanta Healthcare Corporation Information

Table 91. Amanta Healthcare Description and Business Overview

Table 92. Amanta Healthcare Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 93. Amanta Healthcare Intravenous (IV) Solution Product

Table 94. Amanta Healthcare Recent Developments/Updates

Table 95. Terumo Medical Corporation Information

Table 96. Terumo Medical Description and Business Overview

Table 97. Terumo Medical Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 98. Terumo Medical Intravenous (IV) Solution Product

Table 99. Terumo Medical Recent Developments/Updates

Table 100. Grifols Corporation Information

Table 101. Grifols Description and Business Overview

Table 102. Grifols Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 103. Grifols Intravenous (IV) Solution Product

Table 104. Grifols Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Intravenous (IV) Solution Distributors List

Table 108. Intravenous (IV) Solution Customers List

Table 109. Intravenous (IV) Solution Market Trends

Table 110. Intravenous (IV) Solution Market Drivers

Table 111. Intravenous (IV) Solution Market Challenges

Table 112. Intravenous (IV) Solution Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Intravenous (IV) Solution

Figure 2. Global Intravenous (IV) Solution Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Intravenous (IV) Solution Market Share by Type in 2023 & 2030

Figure 4. Total Parenteral Solution Product Picture

Figure 5. Peripheral Parenteral Solution Product Picture

Figure 6. Global Intravenous (IV) Solution Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Intravenous (IV) Solution Market Share by Application in 2023 & 2030

Figure 8. Hospitals & Clinics

Figure 9. Ambulatory

Figure 10. Homecare

Figure 11. Global Intravenous (IV) Solution Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Intravenous (IV) Solution Market Size (2019-2030) & (US$ Million)

Figure 13. Global Intravenous (IV) Solution Sales (2019-2030) & (K MT)

Figure 14. Global Intravenous (IV) Solution Average Price (USD/MT) & (2019-2030)

Figure 15. Intravenous (IV) Solution Report Years Considered

Figure 16. Intravenous (IV) Solution Sales Share by Manufacturers in 2023

Figure 17. Global Intravenous (IV) Solution Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Intravenous (IV) Solution Players: Market Share by Revenue in 2023

Figure 19. Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Intravenous (IV) Solution Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Intravenous (IV) Solution Sales Market Share by Country (2019-2030)

Figure 22. North America Intravenous (IV) Solution Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Intravenous (IV) Solution Sales Market Share by Country (2019-2030)

Figure 26. Europe Intravenous (IV) Solution Revenue Market Share by Country (2019-2030)

Figure 27. Germany Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Intravenous (IV) Solution Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Intravenous (IV) Solution Revenue Market Share by Region (2019-2030)

Figure 34. China Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Intravenous (IV) Solution Sales Market Share by Country (2019-2030)

Figure 45. Latin America Intravenous (IV) Solution Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Intravenous (IV) Solution Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Intravenous (IV) Solution Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. U.A.E Intravenous (IV) Solution Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Intravenous (IV) Solution by Type (2019-2030)

Figure 55. Global Revenue Market Share of Intravenous (IV) Solution by Type (2019-2030)

Figure 56. Global Intravenous (IV) Solution Price (USD/MT) by Type (2019-2030)

Figure 57. Global Sales Market Share of Intravenous (IV) Solution by Application (2019-2030)

Figure 58. Global Revenue Market Share of Intravenous (IV) Solution by Application (2019-2030)

Figure 59. Global Intravenous (IV) Solution Price (USD/MT) by Application (2019-2030)

Figure 60. Intravenous (IV) Solution Value Chain

Figure 61. Intravenous (IV) Solution Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions